An open trial of aripiprazole augmentation for SSRI non‐remitters with late‐life depression

Abstract

In this study 50% of depressed patients not remitting after an adequate trial of an SSRI achieved a final HRSD <or= 10 when given aripiprazole augmentation. Open trials such as this require follow up in a randomized, placebo-controlled trial.